Concord Wealth Partners’s Guardant Health GH Stock Holding History

Concord Wealth Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2K	Buy	+8	New	+$870	﹤0.01%	765
2026 Q1	–	Sell	-8	Closed	-$817	–	422
2025 Q4	$817	Hold	8	–	–	﹤0.01%	734
2025 Q3	$500	Hold	8	–	–	﹤0.01%	770
2025 Q2	$416	Buy	+8	New	+$357	﹤0.01%	793

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Concord Wealth Partners's GH Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Guardant Health (GH) in Q2 2026: 8 shares worth $1.2K. The stake represents ﹤0.01% of the portfolio and ranks #765 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in GH as recently as Q4 2025.

Concord Wealth Partners first reported a position in GH in Q2 2025 and has held it in 4 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Concord Wealth Partners held 8 shares of Guardant Health worth $1.2K as of Q2 2026.
Guardant Health was a new Concord Wealth Partners position in Q2 2026.
Guardant Health made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #765 holding.
Concord Wealth Partners first reported a position in Guardant Health in Q2 2025 and has held it in 4 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.